Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201112198430N2Phase 2Completed
Phase 2 trial of piracetam and rivastigmine in Alzheimer's disease (AD) (2 arms), sponsored by Rafsanjan University of Medical Sciences. Started Mar 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201112198430N2.